UNSPSC 51191509: Mannitol

This classification denotes an osmotic diuretic with the molecular formula C6H14O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3OWL53L36A, chemically known as 1,2,3,4,5,6-hexanehexol but generally known as mannitol, which bears US NIH Compound Identifier 453. European Medicines Agency schedules Mannitol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03087MIG. World Health Organization schedules mannitol in its Anatomical Therapeutic Chemical (ATC) Classification.

UNSPSC 51191509 Mannitol is a Commodity code that encompasses chemical supply products for municipal water treatment and public health operations. State and local governments procure chemical commodities—including sodium bisulfite, pharmaceuticals, and related compounds—under this code for water pollution control facilities, health departments, and other public-serving infrastructure. Recent solicitations show municipalities and state cooperative purchasing alliances buying these chemicals and pharmaceutical products through competitive bid and RFP processes, with pricing evaluated on unit-cost or fixed-price bases and delivery managed through established wholesaler networks or direct municipal procurement. Issuing bodies include city water departments (such as Meriden, Connecticut), state health and administration agencies participating in multistate cooperative purchasing vehicles like MMCAP, and participating state and local facilities across member jurisdictions.

Activity under this code spans Connecticut and the Upper Midwest, with the most recent solicitations originating from the City of Meriden, Connecticut (IFB B027-15 for sodium bisulfite, due July 29, 2026) and the Minnesota Department of Administration's Office of State Procurement administering MMCAP (RFP S1070000015802 for generic pharmaceuticals and OTC products across Minnesota and Oregon, due March 26, 2026). The Meriden solicitation specifies chemical supply for a municipal Water Pollution Control Facility with unit pricing and performance bonding; the MMCAP RFP establishes multi-award contracts for pharmaceutical distribution across state and local member facilities through three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health, and Morris & Dickson Co., LLC), with vendors weighted 75 percent on price competitiveness, 10 percent on fixed pricing, and 5 percent each on administrative compliance, EDI capability, and fee agreement. Both solicitations require comprehensive insurance, FDA or product-quality compliance, and maintenance of contractual relationships with established supply chains.